U.S. markets closed
  • S&P Futures

    3,654.25
    +31.00 (+0.86%)
     
  • Dow Futures

    29,867.00
    +238.00 (+0.80%)
     
  • Nasdaq Futures

    12,381.75
    +104.75 (+0.85%)
     
  • Russell 2000 Futures

    1,841.40
    +21.30 (+1.17%)
     
  • Crude Oil

    44.95
    -0.39 (-0.86%)
     
  • Gold

    1,784.50
    +3.60 (+0.20%)
     
  • Silver

    22.91
    +0.31 (+1.38%)
     
  • EUR/USD

    1.1960
    +0.0026 (+0.22%)
     
  • 10-Yr Bond

    0.8440
    +0.0020 (+0.24%)
     
  • Vix

    20.57
    -0.27 (-1.30%)
     
  • GBP/USD

    1.3356
    +0.0024 (+0.18%)
     
  • USD/JPY

    104.3470
    +0.0230 (+0.02%)
     
  • BTC-USD

    19,661.44
    +151.56 (+0.78%)
     
  • CMC Crypto 200

    385.88
    +21.29 (+5.84%)
     
  • FTSE 100

    6,266.19
    -101.39 (-1.59%)
     
  • Nikkei 225

    26,824.46
    +390.84 (+1.48%)
     

Exelixis Inc (EXEL) EVP and General Counsel Jeffrey Hessekiel Sold $872,337 of Shares

GuruFocus.com
·1 min read

- By insider

EVP and General Counsel of Exelixis Inc (30-Year Financial, Insider Trades) Jeffrey Hessekiel (insider trades) sold 39,742 shares of EXEL on 10/21/2020 at an average price of $21.95 a share. The total sale was $872,337.


Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. The Cabometyx product generates maximum revenue for the company. Exelixis Inc has a market cap of $6.89 billion; its shares were traded at around $22.29 with a P/E ratio of 25.04 and P/S ratio of 7.06.

CFO Recent Trades:

  • EVP and CFO Christopher J. Senner sold 10,000 shares of EXEL stock on 10/08/2020 at the average price of $25. The price of the stock has decreased by 10.84% since.

Directors and Officers Recent Trades:

  • EVP and General Counsel Jeffrey Hessekiel sold 39,742 shares of EXEL stock on 10/21/2020 at the average price of $21.95. The price of the stock has increased by 1.55% since.

For the complete insider trading history of EXEL, click here

.This article first appeared on GuruFocus.